XML 46 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders’ Equity (Deficit) (Details) - USD ($)
 1 Months Ended 3 Months Ended
Feb. 09, 2021
Feb. 09, 2021
Jan. 18, 2021
Mar. 31, 2021
Mar. 10, 2021
Dec. 31, 2020
Nov. 30, 2020
Apr. 30, 2013
Stockholders’ Equity (Deficit) (Details) [Line Items]                
Preferred stock, shares authorized       5,000,000   5,000,000    
Preferred stock, par value (in Dollars per share)       $ 0.0001   $ 0.0001    
Preferred stock value (in Dollars)            
Common Stock issued for conversion of Redeemable Series A Preferred stock, shares       1,000        
Description of preferred stock conversion       The Series C Convertible Preferred Stock and the February Warrants each contain a beneficial ownership limitation that restricts each of the investor’s ability to exercise the February Warrants and convert the Series C Convertible Preferred Stock such that the number of shares of the Company common stock held by each of them and their affiliates after such conversion or exercise does not exceed 4.99% (or, at the election of the Investor, 9.99%) of the Company’s then issued and outstanding shares of common stock.        
Warrants term       5 years        
Exercise price (in Dollars per share)       $ 0.30        
Warrants period date       180 days        
Investor invested percentage       50.00%        
Obligation percentage       1.00%        
Shares of its common stock 4,276 4,276     500,000,000      
Convertible long term notes payable (in Dollars)     $ 8,500,000          
Issued five-year warrants to purchase   14,253,323            
Issued five-year warrants to purchase price per share (in Dollars per share)   $ 4,276            
Aggregate of purchase to common stock   2,850,664            
Common stock issuable percentage   10.00%            
Placement agent warrants, descriptoin       pursuant to the terms of the offering, the Company issued Bradley Woods & Co, Ltd. and Katalyst Securities LLC warrants (the “Placement Agent Warrants”) to purchase up to an aggregate of 2,850,664 shares of common stock, or 10% of the shares of common stock issuable upon conversion of the Series C Preferred Stock and February Warrant Shares sold in the offering. The Placement Agent Warrants are exercisable for a period of five years from the closing date of the offering at an exercise price of $0.35 per share, subject to adjustment.        
Consulting Agreement [Member]                
Stockholders’ Equity (Deficit) (Details) [Line Items]                
Shares of its common stock         100,000,000      
Common stock service, description     The warrants were valued on the grant date at approximately $0.33 per warrant for a total of $83,728 using a Black-Scholes option pricing model with the following assumptions: stock price of $0.35 per share (based on the quoted trading price on the date of grant), volatility of 169%, expected term of five year, and a risk-free interest rate of 0.46%. During the three months ended March 31, 2021, the Company recorded stock-based compensation of $83,728.          
Series A Preferred Stock [Member]                
Stockholders’ Equity (Deficit) (Details) [Line Items]                
Preferred stock, shares authorized               1,000,000
Preferred stock value (in Dollars)       $ 4,280        
Description of preferred stock outstanding       A holder of Series C Convertible Preferred Stock may not convert any portion of the Series C Convertible Preferred Stock to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would own more than 4.99% (or, upon election by a holder prior to issuance, 9.99%) of the outstanding shares of the Company’s common stock after conversion, which beneficial ownership limitation may be increased by the holder up to, but not exceeding, 9.99%.        
Series B Preferred Stock [Member]                
Stockholders’ Equity (Deficit) (Details) [Line Items]                
Preferred stock, shares authorized       2,000   2,000   2,000
Preferred stock, par value (in Dollars per share)       $ 0.0001   $ 0.0001    
Preferred stock value (in Dollars)            
Conversion price per share (in Dollars per share)             $ 0.30  
Description of preferred stock conversion the Company entered into securities purchase agreements (collectively, the “Series C Purchase Agreements”) with certain institutional and accredited investors for the sale of an aggregate of 4,276 shares of the Company’s Series C Convertible Preferred Stock and warrants (the “February Warrants”) to purchase up to 14,253,323 shares (the “February Warrant Shares”) of the Company’s common stock for gross proceeds of approximately $4,276,000, before deducting placement agent and other offering expenses of $481,898 which are offset against the proceeds in additional paid in capital. The offering closed on February 12, 2021. Accordingly, the Company recognized a total deemed dividend of $1,403,997 for the beneficial conversion feature in connection with the issuance of these Series C Convertible Preferred Stock.              
Exercise price (in Dollars per share) $ 0.30 $ 0.30            
Issued five-year warrants to purchase   5